MYB and breast carcinoma: Glucuronidation of fulvestrant and the aromatase inhibitor anastrozole occurs via the UDP-glucuronosyltransferase 1A4 (UGT1A4), which was upregulated by fulvestrant in breast cancer cells via MYB.